High Dose Trial in COPD

PHASE2CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

September 30, 2006

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

BEA 2180 BR

DRUG

tiotropium

Trial Locations (13)

Unknown

Boehringer Ingelheim Investigational Site, Lakewood

Boehringer Ingelheim Investigational Site, Wheat Ridge

Boehringer Ingelheim Investigational Site, Pembroke Farms

Boehringer Ingelheim Investigational Site, Coeur d'Alene

Boehringer Ingelheim Investigational Site, Reno

Boehringer Ingelheim Investigational Site, Larchmont

Boehringer Ingelheim Investigational Site, Winston-Salem

Boehringer Ingelheim Investigational Site, Charleston

Boehringer Ingelheim Investigational Site, Harker Heights

Boehringer Ingelheim Investigational Site, Houston

Boehringer Ingelheim Investigational Site, San Antonio

Boehringer Ingelheim Investigational Site, Richmond

Boehringer Ingelheim Investigational Site, Tacoma

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00128440 - High Dose Trial in COPD | Biotech Hunter | Biotech Hunter